These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 8499959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Skeletal osteoporosis.
    Christiansen C.
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S475-80. PubMed ID: 8122515
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M, Vacca F.
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [Abstract] [Full Text] [Related]

  • 8. Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy.
    Milliken LA, Going SB, Houtkooper LB, Flint-Wagner HG, Figueroa A, Metcalfe LL, Blew RM, Sharp SC, Lohman TG.
    Calcif Tissue Int; 2003 Apr; 72(4):478-84. PubMed ID: 12574871
    [Abstract] [Full Text] [Related]

  • 9. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD.
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [Abstract] [Full Text] [Related]

  • 10. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.
    J Endocrinol Invest; 2005 Sep; 28(10 Suppl):80-4. PubMed ID: 16550729
    [Abstract] [Full Text] [Related]

  • 11. HRT in the prevention and treatment of osteoporosis.
    Delmas PD.
    J Epidemiol Biostat; 1999 Sep; 4(3):155-60; discussion 160-3. PubMed ID: 10695957
    [Abstract] [Full Text] [Related]

  • 12. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 13. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA, Berger ML, Santora AC, Sherwood LM.
    Menopause; 2003 Oct; 10(5):412-9. PubMed ID: 14501602
    [Abstract] [Full Text] [Related]

  • 14. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY.
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [Abstract] [Full Text] [Related]

  • 15. Fracture prevention in elderly women: treatment of osteoporosis is one approach, together with physical exercise and fall prevention.
    Prescrire Int; 1998 Oct; 7(37):155-9. PubMed ID: 10915424
    [Abstract] [Full Text] [Related]

  • 16. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Oct; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 17. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP.
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [Abstract] [Full Text] [Related]

  • 18. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH.
    Arch Intern Med; 2003 Sep 22; 163(17):2052-7. PubMed ID: 14504118
    [Abstract] [Full Text] [Related]

  • 19. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 Sep 22; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 20. [The effect of hormone replacement therapy on bone mineral content and on fractures].
    Eiken PA.
    Ugeskr Laeger; 1997 Jan 27; 159(5):570-6. PubMed ID: 9045445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.